Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26269 | 20807336 | Liver Int | Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. | 2010 | Details |
| A26270 | 20805868 | PLoS One | Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker. | 2010 | Details |
| A26271 | 20805291 | Drug Metab Dispos | Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease. | 2010 | Details |
| A26272 | 20804522 | Obes Rev | Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? | 2010 | Details |
| A26273 | 20803499 | Hepatology | A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. | 2010 | Details |
| A26274 | 20801772 | Gut | Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26275 | 20801631 | J Nutr Biochem | An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat. | 2010 | Details |
| A26276 | 20801629 | J Nutr Biochem | Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. | 2010 | Details |
| A26278 | 20798875 | J Obes | Comparative evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic Fatty liver disease. | 2010 | Details |
| A26280 | 20739079 | J Hepatol | Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26281 | 20734480 | Eksp Klin Gastroenterol | [Use of Legalon in non-alcoholic fatty liver disease]. | 2010 | Details |
| A26282 | 20733515 | J Clin Gastroenterol | The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. | 2011 | Details |
| A26283 | 20731535 | Ups J Med Sci | Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. | 2010 | Details |
| A26284 | 20731130 | Eksp Klin Gastroenterol | [Splenoportal blood flow with nonalcoholic fatty liver disease]. | 2010 | Details |
| A26285 | 20731129 | Eksp Klin Gastroenterol | [The diagnostic significance of ultrasound elastometry in evaluation of fibrosis in chronic diffuse liver diseases]. | 2010 | Details |
| A26286 | 20731108 | Ter Arkh | [Association of obstructive sleep apnea syndrome with the signs of nonalcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome]. | 2010 | Details |
| A26287 | 20728571 | Clin Gastroenterol Hepatol | Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease. | 2010 | Details |
| A26288 | 20721461 | Arq Gastroenterol | Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals. | 2010 | Details |
| A26289 | 20720269 | Ann Hepatol | Prevalence of type 2 diabetes mellitus and chronic liver disease: a retrospective study of the association of two increasingly common diseases in Mexico. | 2010 | Details |
| A26290 | 20720266 | Ann Hepatol | Visceral adipose tissue visfatin in nonalcoholic fatty liver disease. | 2010 | Details |
| A26291 | 20719715 | Orv Hetil | [Symptoms of hepatocellular carcinoma. Laboratory tests used for its diagnosis and screening]. | 2010 | Details |
| A26292 | 20716048 | Exp Clin Transplant | Acute gastric variceal bleeding during orthotopic liver transplant. | 2010 | Details |
| A26293 | 20708005 | Gastroenterology | Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. | 2010 | Details |
| A26294 | 20701585 | Curr Diabetes Rev | Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease. | 2010 | Details |
| A26295 | 20699492 | Indian J Pathol Microbiol | Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients. | 2010 | Details |
| A26296 | 20694293 | Nutr Hosp | Role of -55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity. | 2011 | Details |
| A26297 | 20687985 | Acta Med Port | [Association of gamma glutamyltransferase, metabolic syndrome and cardiovascular risk]. | 2010 | Details |
| A26298 | 20687969 | Br J Nutr | The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. | 2010 | Details |
| A26299 | 20684516 | J Proteome Res | Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. | 2010 | Details |
| A26300 | 20684021 | Hepatology | The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. | 2010 | Details |
| A26301 | 20683463 | Eur J Clin Nutr | Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women. | 2010 | Details |
| A26302 | 20677332 | World J Gastroenterol | Non-viral causes of hepatocellular carcinoma. | 2010 | Details |
| A26303 | 20675984 | Postgrad Med | Sequential changes of serum aminotransferase levels in severely obese patients after losing weight through enrollment in a behavioral weight loss program. | 2010 | Details |
| A26304 | 20675007 | J Hepatol | Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. | 2010 | Details |
| A26305 | 20673376 | Br J Nutr | A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats: possible implication of the sirtuin pathway. | 2010 | Details |
| A26307 | 20666992 | Liver Int | Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease. | 2010 | Details |
| A26308 | 20666689 | Curr Med Res Opin | Population-based risk factors and resource utilization for HCC: US perspective. | 2010 | Details |
| A26309 | 20664958 | Int J Mol Med | Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats. | 2010 | Details |
| A26310 | 20664312 | Korean J Gastroenterol | [Nonalcoholic fatty liver disease]. | 2010 | Details |
| A26311 | 20664019 | Diabetes Care | Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. | 2010 | Details |
| A26312 | 20661251 | Int J Obes (Lond) | Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. | 2010 | Details |
| A26313 | 20661154 | J Clin Gastroenterol | Novel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitis. | 2011 | Details |
| A26314 | 20660697 | Gut | Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. | 2010 | Details |
| A26315 | 20658466 | Hepatology | Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. | 2010 | Details |
| A26316 | 20658156 | J Gastroenterol | Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26317 | 20656836 | Radiology | Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling. | 2010 | Details |
| A26318 | 20655714 | J Nutr Biochem | Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice. | 2010 | Details |
| A26319 | 20655124 | J Hepatol | Down-regulation of SREBP-1c is associated with the development of burned-out NASH. | 2010 | Details |
| A26320 | 20654606 | Clin Chim Acta | The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels. | 2010 | Details |
| A26321 | 20653983 | Lipids Health Dis | Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. | 2010 | Details |
| A26322 | 20651844 | Biochem Cell Biol | Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats. | 2010 | Details |
| A26323 | 20651599 | Eur J Gastroenterol Hepatol | Treatment with omega-3 fatty acids but not exendin-4 improves hepatic steatosis. | 2010 | Details |
| A26325 | 20648476 | Hepatology | Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. | 2010 | Details |
| A26326 | 20648474 | Hepatology | I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. | 2010 | Details |
| A26327 | 20648472 | Hepatology | PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. | 2010 | Details |
| A26328 | 20647417 | Ann Pharmacother | Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. | 2010 | Details |
| A26329 | 20645852 | Annu Rev Nutr | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. | 2010 | Details |
| A26330 | 20644649 | PLoS One | High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. | 2010 | Details |
| A26331 | 20642104 | Pol Merkur Lekarski | [Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease]. | 2010 | Details |
| A26332 | 20637154 | Zhongguo Dang Dai Er Ke Za Zhi | [Relationship between nonalcoholic fatty liver disease and cardiovascular disease in children with obesity]. | 2010 | Details |
| A26334 | 20634799 | Am J Hypertens | Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study. | 2010 | Details |
| A26335 | 20631297 | J Lipid Res | Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2010 | Details |
| A26336 | 20629985 | J Cell Mol Med | High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia. | 2010 | Details |
| A26337 | 20628364 | Am J Gastroenterol | Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. | 2010 | Details |
| A26338 | 20627036 | Zhonghua Nei Ke Za Zhi | [Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease]. | 2010 | Details |
| A26339 | 20626336 | Curr Vasc Pharmacol | Hypocholesterolemia. | 2011 | Details |
| A26340 | 20625834 | Mol Biol Rep | Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people. | 2010 | Details |
| A26341 | 20625773 | J Gastroenterol | Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease. | 2010 | Details |
| A26342 | 20625647 | Arq Bras Endocrinol Metabol | Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2010 | Details |
| A26343 | 20624660 | J Hepatol | Hepatocellular ballooning in NASH. | 2010 | Details |
| A26344 | 20624207 | Liver Int | The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis. | 2010 | Details |
| A26345 | 20624171 | Eur J Clin Invest | Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26347 | 20619918 | J Hepatol | Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. | 2010 | Details |
| A26348 | 20619513 | Clin Nutr | The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. | 2010 | Details |
| A26349 | 20618457 | Hepatol Res | Genetic analysis of expression profile involved in retinoid metabolism in non-alcoholic fatty liver disease. | 2010 | Details |
| A26350 | 20608031 | Lik Sprava | [Efficiency of complex therapy in the treatment of non-alcoholic steatohepatitis and prevention of liver fibrosis]. | 2010 | Details |
| A26351 | 20607654 | Histol Histopathol | A role for mammalian target of rapamycin (mTOR) pathway in non alcoholic steatohepatitis related-cirrhosis. | 2010 | Details |
| A26352 | 20606731 | Int J Clin Exp Pathol | Expression of fatty acid synthase in nonalcoholic fatty liver disease. | 2010 | Details |
| A26353 | 20604719 | Scand J Clin Lab Invest | Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26354 | 20602679 | Liver Int | Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians. | 2010 | Details |
| A26355 | 20602678 | Liver Int | Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes. | 2010 | Details |
| A26356 | 20601094 | Drug Discov Today | Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation? | 2010 | Details |
| A26357 | 20600152 | Life Sci | Hyperglycemia-induced mitochondrial alterations in liver. | 2010 | Details |
| A26358 | 20600015 | Gastroenterology | Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. | 2010 | Details |
| A26359 | 20594607 | J Hepatol | In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry. | 2010 | Details |
| A26360 | 20594230 | J Gastroenterol Hepatol | Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver. | 2010 | Details |
| A26361 | 20590731 | Diabetes Obes Metab | Acupuncture: is it effective for treatment of insulin resistance? | 2010 | Details |
| A26362 | 20587319 | Zhonghua Gan Zang Bing Za Zhi | [The relationship of leptin and adiponectin with insulin resistance in nonalcoholic fatty liver disease]. | 2010 | Details |
| A26363 | 20584330 | BMC Gastroenterol | Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). | 2010 | Details |
| A26364 | 20584230 | Int J Clin Pract | Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease. | 2010 | Details |
| A26365 | 20582634 | Sleep Breath | An experimental research on chronic intermittent hypoxia leading to liver injury. | 2010 | Details |
| A26366 | 20581244 | Gut | Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. | 2010 | Details |
| A26367 | 20580331 | Dig Liver Dis | Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease. | 2010 | Details |
| A26368 | 20580037 | Metabolism | Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26369 | 20579864 | J Nutr Biochem | Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. | 2010 | Details |
| A26370 | 20578268 | Hepatology | A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. | 2010 | Details |
| A26371 | 20578153 | Hepatology | Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. | 2010 | Details |
| A26372 | 20576005 | Obes Rev | Melanin and melanogenesis in adipose tissue: possible mechanisms for abating oxidative stress and inflammation? | 2011 | Details |
| A26373 | 20547306 | Dig Liver Dis | Hepatocellular carcinoma: New and emerging risks. | 2010 | Details |
| A26374 | 20572063 | J Clin Ultrasound | Correlation of hepatic vein Doppler waveform and hepatic artery resistance index with the severity of nonalcoholic fatty liver disease. | 2010 | Details |